Western Europe Companion Animal Healthcare Market, by End User, 2018-2027
| Label | Anti-Infectives | Antibiotics | Anti-Inflammatories | Others |
|---|---|---|---|---|
| 2018 | 510.73 USD Mn | 380.89 USD Mn | 250.35 USD Mn | 375.35 USD Mn |
| 2019 | 543.34 USD Mn | 404.61 USD Mn | 269.46 USD Mn | 401.61 USD Mn |
| 2020 | 572.25 USD Mn | 425.51 USD Mn | 287.12 USD Mn | 425.42 USD Mn |
| 2021 | 612.48 USD Mn | 454.74 USD Mn | 310.87 USD Mn | 457.95 USD Mn |
| 2022 | 656.69 USD Mn | 486.83 USD Mn | 337.16 USD Mn | 493.83 USD Mn |
| 2023 | 705.35 USD Mn | 522.12 USD Mn | 366.31 USD Mn | 533.48 USD Mn |
| 2024 | 759.02 USD Mn | 560.99 USD Mn | 398.69 USD Mn | 577.37 USD Mn |
| 2025 | 818.3 USD Mn | 603.88 USD Mn | 434.73 USD Mn | 626.06 USD Mn |
| 2026 | 883.92 USD Mn | 651.29 USD Mn | 474.9 USD Mn | 680.16 USD Mn |
| 2027 | 956.69 USD Mn | 703.8 USD Mn | 519.78 USD Mn | 740.39 USD Mn |
Data Source: Wantstats Repository
Growth Outlook
- The 2027 portion of the Western Europe Companion Animal Healthcare Market, by Pharmaceuticals, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 2690 Mn in 2026 and is projected to reach USD 2921 Mn by 2027 — a gain of about 9% over the forecast period, translating to a CAGR in the high single digits.
- 2027: Anti-Infectives leads this comparison at 956. 69M USD — 33% of the combined total across all 4 groups shown.
- What the regional split looks like (2026): Anti-Infectives leads, holding roughly 33% of segment value — the single largest regional share. Others is the second-largest contributor. Antibiotics and Anti-Inflammatories make up the remainder, in descending order.
- By 2027, Anti-Infectives alone is expected to reach USD 957 Mn, with Others at USD 740 Mn.
Market Dynamics
2027: Anti-Infectives leads this comparison at 956.69M USD — 33% of the combined total across all 4 groups shown.
Next is Others, at 740.39M USD — 23% behind Anti-Infectives.
Anti-Infectives climbs from 510.73M USD (2018) to 956.69M USD (2027), a 87% gain.
Others: 375.35M USD to 740.39M USD, 97% higher by 2027.
Antibiotics: 380.89M USD in 2018 to 703.80M USD by 2027, up 85%.
Anti-Inflammatories grows to 519.78M USD by 2027, from 250.35M USD in 2018 — 108% up.
Anti-Inflammatories grows fastest of the group, 108% from 2018 to 2027 — starting smaller doesn't mean staying smaller at this pace.
Across the full group, the combined total moves from 1.52B USD in 2018 to 2.92B USD in 2027 — a 92% change.
How The 4 Series Compare
This is a comparison chart, 4 groups at once — the interesting question is usually how the gap between them changes, not the value of any single group in isolation.
The largest series today is not guaranteed to stay largest — check the growth rate of each group, not just its current size, before projecting the ranking forward.
The most practical way to read this is relative: set the Western Europe Companion Animal Healthcare market figures beside other regions or segments of the same market to see where growth is concentrated.
This is a market research forecast, not an official statistic. Values after the 2018 base year are modeled projections to 2027, based on supply-side and demand-side analysis, and are updated when market conditions change.
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Related Charts
View AllWestern Europe Companion Animal Healthcare Market, by Diagnostics, 2018-2027
Western Europe Companion Animal Healthcare Market, by Feed Additives, 2018-2027
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence



